In Person Special Seminar: Exercise in a Pill: A Chemist Approach and Drugging the S1P Pathway; and a Discussion of the Virginia Tech Center for Drug Discovery
Webster L. Santos, Ph.D.
Professor
Agnes and Cliff Lilly Fellow of Drug Discovery
Department of Chemistry
College of Science
Director, Center for Drug Discover
Virginia Tech
In Person Seminar: Connexin 43: Exercise in a Pill: A Chemist Approach and Drugging the S1P Pathway; and a Discussion of the Virginia Tech Center for Drug Discovery
Date: Feb. 22, 2023
Time: 1 p.m.
About this Seminar
In this presentation, Dr. Santos will highlight his team’s investigations on developing small molecule protonophores selective for mitochondria as potential treatment for obesity and fatty liver disease. The goal is to develop molecules that increase energy expenditure without the need for exercise. On the next part, Dr. Santos will discuss developing inhibitors of proteins in the sphingosine-1-phosphate (S1P) pathway for the treatment of multiple sclerosis and chronic kidney disease. S1P is an endogenous signaling molecule that functions as a chemotactic agent that is important in inflammation, fibrosis, and cancer. In both programs, the medicinal chemistry approach, assay development, and in vivo studies will be presented. Finally, he will discuss the VT Center for Drug Discovery and potential collaborations.
You May Also Be Interested In...
-
Home ItemSocial Learning in Borderline Personality Disorder , home
April 4, 2025, 11:00 a.m. | Sarah Fineberg, M.D., Ph.D., Assistant Professor, Department of Psychiatry, Yale School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research
-
Home ItemBringing Precision Medicine to Psychiatry , home
April 10, 2025, 5:30 p.m. (Reception at 5 p.m.) | Jordan Smoller, M.D., Sc.D., Massachusetts General Hospital Trustees Endowed Chair in Psychiatric Neuroscience; Professor of Psychiatry, Harvard Medical School; Professor of Epidemiology, T.H. Chan Harvard School of Public Health; Director, Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital | Maury Strauss Distinguished Public Lecture
-
Home ItemExtracellular Vesicles in the Pathogenesis, Diagnosis and Treatment of the Heart , home
April 11, 2025, 11:00 a.m. | Susmita Sahoo, Ph.D., Associate Professor, Department of Medicine and Cardiology, Icahn School of Medicine at Mount Sinai | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
-
Home ItemA Human-Centric View of Cerebellar Development , home
April 18, 2025, 11:00 a.m. | Kathleen Millen, Ph.D., Professor, Department of Pediatrics/Genetics, Associate Director and Principal Investigator, Seattle Children's Hospital Research Institute, The University of Washington School of Medicine | Co-Sponsored by the Center for Neurobiology Research, Fralin Biomedical Research Institute
-
Home ItemMolecular and Neurobiological Studies in Rett Syndrome and Other MECP2 Disorders , home
May 1, 2025, 5:30 p.m. (Reception at 5 p.m.) | Huda Zoghbi, M.D., Professor, Pediatrics, Molecular and Human Genetics, Neuroscience, and Neurology; Director, Jan and Dan Duncan Neurological Research Institute, Baylor College of Medicine; Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture
-
Home ItemA Novel Bispecific Antibody to Target the Brain Tumor Microenvironment , home
May 2, 2025, 11:00 a.m. | Khuson Yun, Ph.D., Associate Professor, Department of Neurology, Houston Methodist Chair, Neurodegenerative Disease Research, Houston Methodist Research Institute, Weill Cornell Medical College | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke